Obstacles to the HIV Endgame: Science and Society

Obstacles to the HIV Endgame: Science and Society

Please join us for an interactive, interdisciplinary program with plenaries, group discussion, breakout sessions, and a poster session featuring work from early stage investigators.

The goal of this symposium is to stimulate interaction and discussion across bench, clinical, translational, and implementation science, and to promote new ideas and collaborations to energize our work in this critical moment.

Topics include:

• How can we maximize access and impact of long-acting antivirals and other emerging interventions?
• How can we ensure that a focus on new modalities doesn’t derail or displace existing effective approaches?
• How do we conceptualize what new modalities and interventions do/do not need to be developed given the efficacy of our current prevention and care toolkit?
• How do we reimagine and redesign care delivery to increase access for the 27% of individuals traditionally left behind in our 90/90/90 goals?

Keynote speakers include:

Sarah Braunstein, PhD, MPH

Assistant Commissioner, Bureau of Hepatitis, HIV and STI

NYC Department of Health and Mental Hygeine

Connie Celum, MD, MPH

Professor of Global Health, Medicine and Epidemiology

Director of the International Clinical Research Center

University of Washington

Chibuzo Enemchukwu, MD, MS

Assistant Chief, Department of Medicine

Clinical Education & Population Health Initiatives

Viral Hepatitis and HIV Clinical Care Coordination (Medspan)

NYC Health+Hospitals - Correctional Health Services

Jeffrey Lifson, MD

Director AIDS and Cancer Virus Program

Frederick National Laboratory

Sharon Nachman, MD

Professor of Pediatrics and Associate Dean for Research

SUNY Stony Brook

PI, International Maternal Pediatric Adolescent AIDS Clinical Network (IMPAACT)

Rupa R. Patel, MD, MPH, FIDSA

Biomedical HIV Prevention Advisor (Voluntary)

Community Health Department, Whitman-Walker Health